Results 201 to 210 of about 415,200 (261)

Circulating Adipokines in Alcohol-Related Liver Disease and MetALD: A Systematic Review and Structured Narrative Synthesis. [PDF]

Int J Mol Sci
Mirowski K, Balicka-Ślusarczyk B, Skladany L, Arab JP, Grgurevic I, Kukla M.   +5 more
europepmc   +1 more source

The impact of harm reduction interventions on injection‐related bacterial infections among people who inject drugs: A systematic review

Addiction, EarlyView.
Abstract Background and aims Injection‐related bacterial infections represent a major but under‐recognised health issue among people who inject drugs (PWID). Harm reduction interventions (HRIs) like needle and syringe programmes (NSP) and opioid agonist treatment (OAT) could mitigate their burden.
Anthony Cousien, Lobna Tijani, Nadia Hachicha, Manon Godart, Mathieu Castry, Karen Champenois, Perrine Roux, Sylvie Deuffic‐Burban   +7 more
wiley   +1 more source

Xanthoxylin Protects Against Alcoholic Liver Injury via the EGFR/AKT Pathway: A Combined In Silico and In Vitro Study. [PDF]

Molecules
Li X, Lan Y, Xue C, Yang K, He L, Sheng J, Wang J, Sun P.   +7 more
europepmc   +1 more source

Prognostic significance of prior alcohol use disorder in patients with presumed metabolic dysfunction‐associated steatotic liver disease: A large multi‐center cohort study

Addiction, EarlyView.
Abstract Background and aims Alcohol use disorder (AUD) follows a chronic, relapsing course but is often overlooked when alcohol consumption is minimal at the time of evaluation. We aimed to assess the prognostic impact of a prior AUD diagnosis on liver‐related outcomes in patients with presumed metabolic dysfunction‐associated steatotic liver disease (
Butros Fakhoury, Jinye Liu, Vinay Jahagirdar, Kaanthi Rama, Gerald Scott Winder, Luis Antonio Díaz, Juan Pablo Arab   +6 more
wiley   +1 more source

Short-Term Risk Stratification in Alcohol-Associated Hepatitis: Small HDL Particles and Inflammation Vulnerability Index Values Improve Model for End-Stage Liver Disease. [PDF]

Alcohol Clin Exp Res (Hoboken)
Vilar-Gomez E, Connelly MA, Shah VH, Shalaurova I, Rafalko JM, Sanyal AJ, Chalasani NP, Gawrieh S, TREAT Consortium.   +8 more
europepmc   +1 more source

Age, period and cohort effects in alcohol‐related liver disease mortality in the United States, 1968 to 2023

Addiction, EarlyView.
Abstract Aims Over the past two decades, mortality from alcohol‐related liver disease has rapidly increased in the United States. We aimed to describe age, period and cohort contributions to alcohol‐related liver disease mortality to better understand the possible drivers of recent worsening trends.
Joseph Alejandro, J. Travis Donahoe, Natalie Sumetsky, Christina Mair   +3 more
wiley   +1 more source

HIV Testing and Care Among Publicly Insured Enrollees With Schizophrenia: Is There a Benefit to Dual Eligibility? [PDF]

Psychiatr Res Clin Pract
Murphy K, Thomas MD, Alonso-Fraire P, Bazazi AR, Dahiya P, Olfson M, Cournos F, Arnold E, Dilley J, Wesson P, Hermida R, Walkup J, Crystal S, Mangurian C.   +13 more
europepmc   +1 more source

The association between chronic pain and non‐fatal overdose in people who inject drugs: Longitudinal cohort study in Montreal, Canada, 2017 to 2025

Addiction, EarlyView.
Abstract Background and aims The prevalence of chronic pain is elevated among people who inject drugs. Chronic pain may motivate drug use, potentially increasing the risk of non‐fatal overdose. We aimed to estimate the association between chronic pain and non‐fatal overdose in people who inject drugs.
Sarah Larney, Geng Zang, Harika Dasari, M. Gabrielle Pagé, Farzaneh Vakili, Adelina Artenie, Valérie Martel‐Laferrière, Nanor Minoyan, Sasha Udhesister, Julie Bruneau   +9 more
wiley   +1 more source

Retrospective analysis of predictors for significant hepatic inflammation in metabolic-associated fatty liver disease with chronic hepatitis B. [PDF]

PeerJ
Xu LH, He RY, Kang YN, Lin HH, Yang JE, Chen HX, Huang XT, Wu XL, Pei BH, Zhou C, Wang M.   +10 more
europepmc   +1 more source

Clinical Need and Research Investment for Liver Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Liver cancer incidence and mortality rates have been rising in comparison to other common cancers, but research funding has not been commensurate. ABSTRACT Aim This study aims to better understand factors driving the rising burden and costs of primary liver cancer (PLC) in Australia, identify key epidemiological trends, and ascertain investment in PLC ...
Romario Nguyen, Fatema Safri, Ankur Sharma, Jessica Howell, Stuart K. Roberts, Simone I. Strasser, Amany Zekry, Alan Wigg, Leon A. Adams, Michael Wallace, Golo Ahlenstiel, Eleonora Feletto, Karen Canfell, Tracey O'Brien, Jacob George, Liang Qiao   +15 more
wiley   +1 more source